Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors

It has been indicated that proton pump inhibitor (PPI) use is associated with a loss of the anti-fracture efficacy of alendronate (AD). However, there are few prospective studies that have investigated the efficacy of AD on lumbar bone mineral density (BMD) in osteoporotic patients who are using PPI...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Biomed Rep
Hlavní autoři: Asaoka, Daisuke, Nagahara, Akihito, Hojo, Mariko, Matsumoto, Kenshi, Ueyama, Hiroya, Matsumoto, Kohei, Izumi, Kentaro, Takeda, Tsutomu, Komori, Hiroyuki, Akazawa, Yoichi, Shimada, Yuji, Osada, Taro, Watanabe, Sumio
Médium: Artigo
Jazyk:Inglês
Vydáno: D.A. Spandidos 2016
Témata:
Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4950806/
https://ncbi.nlm.nih.gov/pubmed/27446535
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2016.710
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky